These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 21546127)
1. [Tracheostomy cannula as a cause of false positive result on the whole-body scan with (131)I in the follow-up of differentiated thyroid cancer]. Vallejo Casas JA; Mena Bares ML; Gálvez Moreno MA; Latre Romero JM Rev Esp Med Nucl; 2011; 30(6):384-5. PubMed ID: 21546127 [No Abstract] [Full Text] [Related]
2. Nasoalveolar cyst as a cause of false positive result in post-therapy 131I whole body scintigraphy. García-Talavera P; Ruiz MÁ; Montes AA; Gamazo C; González ML; Olmos R Rev Esp Med Nucl Imagen Mol; 2012 Sep; 31(5):288-9. PubMed ID: 23067534 [No Abstract] [Full Text] [Related]
3. Accumulation of (131)INa activity in renal cysts unrelated to metastatic disease in a patient with differentiated thyroid cancer. Castillo-Berrio C; Zelaya F; Loira F; Castrillón M; López A; Outomuro J Rev Esp Med Nucl Imagen Mol; 2016; 35(1):70-1. PubMed ID: 26144698 [No Abstract] [Full Text] [Related]
4. Stunning with 131I diagnostic whole-body imaging of patients with thyroid cancer. Gerard SK; Dam HQ Radiology; 2005 Mar; 234(3):972-3; author reply 973-4. PubMed ID: 15734947 [No Abstract] [Full Text] [Related]
5. Disseminated bone metastases from occult thyroid cancer effectively treated with debulking surgery and a single dosimetry-guided administration of radioiodine. Borsò E; Boni G; Mazzarri S; Cocciaro A; Gambacciani C; Traino AC; Manca G; Grosso M; Scatena C; Ortenzi V; Vannozzi R; Marzola MC; Rubello D; Mariani G Rev Esp Med Nucl Imagen Mol; 2015; 34(2):111-5. PubMed ID: 25455505 [TBL] [Abstract][Full Text] [Related]
6. Follow-up of differentiated thyroid cancer. Pacini F Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S492-6. PubMed ID: 12192551 [TBL] [Abstract][Full Text] [Related]
7. Thyroid carcinoma in a newborn: clinical challenges in managing the first recorded case. Estevão-Costa J; Gil-Da-Costa MJ; Medina AM; Sobrinho-Simões M Med Pediatr Oncol; 2000 Apr; 34(4):290-2. PubMed ID: 10742075 [No Abstract] [Full Text] [Related]
8. False-positive findings on (131)I whole-body scans because of posttraumatic superficial scabs. Regalbuto C; Buscema M; Arena S; Vigneri R; Squatrito S; Pezzino V J Nucl Med; 2002 Feb; 43(2):207-9. PubMed ID: 11850486 [TBL] [Abstract][Full Text] [Related]
9. [Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: a possible course]. Gutiérrez Cardo AL; Rodríguez Rodríguez JR; Borrego Dorado I; Navarro González E; Tirado Hospital JL; Vázquez Albertino R Rev Esp Med Nucl; 2007; 26(3):138-45. PubMed ID: 17524307 [TBL] [Abstract][Full Text] [Related]
10. 131I therapeutic efficacy is not influenced by stunning after diagnostic whole-body scanning. Dam HQ; Kim SM; Lin HC; Intenzo CM Radiology; 2004 Aug; 232(2):527-33. PubMed ID: 15286323 [TBL] [Abstract][Full Text] [Related]
11. Cutaneous metastasis from follicular carcinoma of the thyroid gland. Caron P; Moreau-Cabarrot A; Gorguet B; Bazex J Thyroid; 1993; 3(3):235-7. PubMed ID: 8257865 [TBL] [Abstract][Full Text] [Related]
12. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer. de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550 [TBL] [Abstract][Full Text] [Related]
13. Mediastinal images resembling thymus following 131-I treatment for thyroid cancer. Montella L; Caraglia M; Abbruzzese A; Soricelli A; Caputi M; Squame G; Salvatore M; Del Prete S; Palmieri G Monaldi Arch Chest Dis; 2005 Jun; 63(2):114-7. PubMed ID: 16128228 [TBL] [Abstract][Full Text] [Related]
14. Radioiodine therapy for papillary and follicular thyroid carcinoma. Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549 [TBL] [Abstract][Full Text] [Related]
15. [Iodine uptake in the chest in the follow-up of well-differentiated thyroid cancer]. García Alonso MP; Balsa Bretón MA; Paniagua Correa C; Castillejos Rodríguez L; Penín González FJ; Elviro Peña R; Ortega Valle A; Mariana Monguía A; Vásquez Tineo SI; Mendoza Paulini A; Pey Illera C Rev Esp Med Nucl; 2011; 30(1):24-8. PubMed ID: 20863596 [TBL] [Abstract][Full Text] [Related]
16. False-positive I-131 whole-body imaging after I-131 therapy for a follicular carcinoma. Andreas J; Brühl K; Eissner D Clin Nucl Med; 1997 Feb; 22(2):123-4. PubMed ID: 9031774 [No Abstract] [Full Text] [Related]
17. Lung metastases in patients with differentiated thyroid carcinoma and evaluation of response to radioiodine therapy. Kalender E; Zeki Celen Y; Elboga U; Deniz Demir H; Yilmaz M Rev Esp Med Nucl Imagen Mol; 2012; 31(6):328-31. PubMed ID: 23084016 [TBL] [Abstract][Full Text] [Related]
18. Vascular retention of Tc-99m pertechnetate and Tc-99m sestamibi, mimicking thyroid carcinoma metastases. Tuncel M; Ozgen Kiratli P Rev Esp Med Nucl; 2007; 26(4):226-9. PubMed ID: 17662189 [No Abstract] [Full Text] [Related]
19. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196 [TBL] [Abstract][Full Text] [Related]
20. [Should thyroxine treatment be discontinued for four weeks before I(131) thyroid ablation?]. Luna R; Penín M; Seoane I; Alvarez E; Palmeiro R; García-Mayor R Endocrinol Nutr; 2012 Apr; 59(4):227-31. PubMed ID: 22436880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]